A detailed history of Wfa Asset Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Wfa Asset Management Corp holds 1,524 shares of ABT stock, worth $174,086. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,524
Previous 1,517 0.46%
Holding current value
$174,086
Previous $158 Million 10.27%
% of portfolio
0.09%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$100.07 - $118.13 $700 - $826
7 Added 0.46%
1,524 $174 Million
Q2 2024

Jul 19, 2024

BUY
$100.73 - $112.44 $805 - $899
8 Added 0.53%
1,517 $158 Million
Q1 2024

Apr 18, 2024

BUY
$109.52 - $120.96 $876 - $967
8 Added 0.53%
1,509 $171 Million
Q4 2023

May 24, 2024

BUY
$90.19 - $110.4 $631 - $772
7 Added 0.47%
1,501 $165 Million
Q4 2023

Jan 31, 2024

BUY
$90.19 - $110.4 $631 - $772
7 Added 0.47%
1,501 $165 Million
Q3 2023

May 24, 2024

SELL
$95.53 - $114.62 $1,432 - $1,719
-15 Reduced 0.99%
1,494 $145 Million
Q3 2023

Oct 13, 2023

BUY
$95.53 - $114.62 $5,922 - $7,106
62 Added 4.33%
1,494 $145 Million
Q2 2023

Oct 13, 2023

BUY
$100.78 - $112.29 $705 - $786
7 Added 0.49%
1,432 $156 Million
Q1 2023

Oct 13, 2023

BUY
$96.86 - $114.01 $678 - $798
7 Added 0.49%
1,425 $144 Million
Q4 2022

Oct 13, 2023

BUY
$95.06 - $111.52 $570 - $669
6 Added 0.42%
1,418 $156 Million
Q3 2022

Oct 13, 2023

BUY
$96.76 - $112.03 $580 - $672
6 Added 0.43%
1,412 $137 Million
Q2 2022

Oct 13, 2023

SELL
$102.07 - $123.37 $2,449 - $2,960
-24 Reduced 1.68%
1,406 $153 Million
Q1 2022

Oct 13, 2023

BUY
$114.02 - $139.04 $570 - $695
5 Added 0.35%
1,430 $169 Million
Q4 2021

Oct 13, 2023

BUY
$115.53 - $141.46 $164,630 - $201,580
1,425 New
1,425 $201 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Wfa Asset Management Corp Portfolio

Follow Wfa Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wfa Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Wfa Asset Management Corp with notifications on news.